Immunoenzyme Techniques

"Immunoenzyme Techniques" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.

Descriptor ID	D007124
MeSH Number(s)	E05.478.566.350 E05.478.583.400 E05.601.470.350
Concept/Terms	Immunoenzyme Techniques Immunoenzyme Techniques Immunoenzyme Technique Technique, Immunoenzyme Techniques, Immunoenzyme Immunoenzyme Technics Immunoenzyme Technic Technic, Immunoenzyme Technics, Immunoenzyme Peroxidase-Antiperoxidase Complex Technique Peroxidase-Antiperoxidase Complex Technique Peroxidase Antiperoxidase Complex Technique Peroxidase-Antiperoxidase Complex Techniques Technique, Peroxidase-Antiperoxidase Complex Techniques, Peroxidase-Antiperoxidase Complex Peroxidase-Antiperoxidase Complex Technic Peroxidase Antiperoxidase Complex Technic Peroxidase-Antiperoxidase Complex Technics Technic, Peroxidase-Antiperoxidase Complex Technics, Peroxidase-Antiperoxidase Complex Peroxidase-Labeled Antibody Technique Peroxidase-Labeled Antibody Technique Antibody Technique, Peroxidase-Labeled Antibody Techniques, Peroxidase-Labeled Peroxidase Labeled Antibody Technique Peroxidase-Labeled Antibody Techniques Technique, Peroxidase-Labeled Antibody Techniques, Peroxidase-Labeled Antibody Peroxidase-Labeled Antibody Technic Antibody Technic, Peroxidase-Labeled Antibody Technics, Peroxidase-Labeled Peroxidase Labeled Antibody Technic Peroxidase-Labeled Antibody Technics Technic, Peroxidase-Labeled Antibody Technics, Peroxidase-Labeled Antibody Enzyme-Labeled Antibody Technique Enzyme-Labeled Antibody Technique Antibody Technique, Enzyme-Labeled Antibody Techniques, Enzyme-Labeled Enzyme Labeled Antibody Technique Enzyme-Labeled Antibody Techniques Technique, Enzyme-Labeled Antibody Techniques, Enzyme-Labeled Antibody Enzyme-Labeled Antibody Technic Antibody Technic, Enzyme-Labeled Antibody Technics, Enzyme-Labeled Enzyme Labeled Antibody Technic Enzyme-Labeled Antibody Technics Technic, Enzyme-Labeled Antibody Technics, Enzyme-Labeled Antibody Antibody Enzyme Technique, Unlabeled Antibody Enzyme Technique, Unlabeled Antibody Enzyme Technic, Unlabeled Enzyme Immunoassay Enzyme Immunoassay Enzyme Immunoassays Immunoassays, Enzyme Immunoassay, Enzyme Immunoperoxidase Techniques Immunoperoxidase Techniques Immunoperoxidase Technique Technique, Immunoperoxidase Techniques, Immunoperoxidase Immunoperoxidase Technics Immunoperoxidase Technic Technic, Immunoperoxidase Technics, Immunoperoxidase

Below are MeSH descriptors whose meaning is more general than "Immunoenzyme Techniques".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Immunologic Techniques [E05.478]
Immunoassay [E05.478.566]
Immunoenzyme Techniques [E05.478.566.350]
Immunohistochemistry [E05.478.583]
Immunoenzyme Techniques [E05.478.583.400]
Molecular Probe Techniques [E05.601]
Immunoassay [E05.601.470]
Immunoenzyme Techniques [E05.601.470.350]

Below are MeSH descriptors whose meaning is related to "Immunoenzyme Techniques".

Below are MeSH descriptors whose meaning is more specific than "Immunoenzyme Techniques".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunoenzyme Techniques" by people in this website by year, and whether "Immunoenzyme Techniques" was a major or minor topic of these publications.

Bar chart showing 56 publications over 19 distinct years, with a maximum of 8 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	0	1	1
1994	0	1	1
1998	0	1	1
1999	0	2	2
2000	0	2	2
2002	0	1	1
2003	0	5	5
2004	0	5	5
2005	0	3	3
2006	0	2	2
2007	0	2	2
2008	1	2	3
2009	0	7	7
2010	0	8	8
2011	1	3	4
2012	0	3	3
2013	0	1	1
2014	0	3	3
2015	0	2	2

Below are the most recent publications written about "Immunoenzyme Techniques" by people in Profiles.

Wang M, Devarajan K, Singal AG, Marrero JA, Dai J, Feng Z, Rinaudo JA, Srivastava S, Evans A, Hann HW, Lai Y, Yang H, Block TM, Mehta A. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma. Cancer Prev Res (Phila). 2016 Feb; 9(2):172-9.

View in: PubMed
Jin S, Merchant ML, Ritzenthaler JD, McLeish KR, Lederer ED, Torres-Gonzalez E, Fraig M, Barati MT, Lentsch AB, Roman J, Klein JB, Rane MJ. Baclofen, a GABABR agonist, ameliorates immune-complex mediated acute lung injury by modulating pro-inflammatory mediators. PLoS One. 2015; 10(4):e0121637.

View in: PubMed
Cui Y, Wilder J, Rietz C, Gigliotti A, Tang X, Shi Y, Guilmette R, Wang H, George G, Nilo de Magaldi E, Chu SG, Doyle-Eisele M, McDonald JD, Rosas IO, El-Chemaly S. Radiation-induced impairment in lung lymphatic vasculature. Lymphat Res Biol. 2014 Dec; 12(4):238-50.

View in: PubMed
Gross ND, Bauman JE, Gooding WE, Denq W, Thomas SM, Wang L, Chiosea S, Hood BL, Flint MS, Sun M, Conrads TP, Ferris RL, Johnson JT, Kim S, Argiris A, Wirth L, Nikiforova MN, Siegfried JM, Grandis JR. Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer. Clin Cancer Res. 2014 Jun 15; 20(12):3289-98.

View in: PubMed
Williams AD, Sanchez A, Hou JS, Rubin RR, Hysell ME, Babcock BD, Shaikh MF, Weingarten MS, Bowne WB. Retroperitoneal Castleman's disease: advocating a multidisciplinary approach for a rare clinical entity. World J Surg Oncol. 2014 Feb 04; 12:30.

View in: PubMed
Hamilton KE, Noubissi FK, Katti PS, Hahn CM, Davey SR, Lundsmith ET, Klein-Szanto AJ, Rhim AD, Spiegelman VS, Rustgi AK. IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts. Carcinogenesis. 2013 Nov; 34(11):2647-54.

View in: PubMed
Carrio R, Koru-Sengul T, Miao F, Glück S, Lopez O, Selman Y, Alvarez C, Milikowski C, Gomez C, Jorda M, Nadji M, Torroella-Kouri M. Macrophages as independent prognostic factors in small T1 breast cancers. Oncol Rep. 2013 Jan; 29(1):141-8.

View in: PubMed
Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol. 2012 Nov; 19(12):3879-87.

View in: PubMed
Soliera AR, Mariani SA, Audia A, Lidonnici MR, Addya S, Ferrari-Amorotti G, Cattelani S, Manzotti G, Fragliasso V, Peterson L, Perini G, Holyoake TL, Calabretta B. Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1. Leukemia. 2012 Jul; 26(7):1555-63.

View in: PubMed
Wilson WH, Jung SH, Porcu P, Hurd D, Johnson J, Martin SE, Czuczman M, Lai R, Said J, Chadburn A, Jones D, Dunleavy K, Canellos G, Zelenetz AD, Cheson BD, Hsi ED. A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 2012 May; 97(5):758-65.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement